In LGLL patients, STAT3 mutations have been associated with gene alterations on TNFAIP3 which is a gene responsible for encoding an NF-kB signaling inhibitor called A20 (52, 53). This evidence concerns the gene STAT3 and T-cell large granular lymphocyte leukemia.